Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 3 × Persistent Infection × Papillomavirus Vaccines × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Papillomavirus Infections 9 Uterine Cervical Neoplasms 7 Condylomata Acuminata 3 Whooping Cough 1 Vulvar Neoplasms 1 Vaginal Neoplasms 1 Uterine Cervical Dysplasia 1 Tetanus 1 Persistent Infection 1 Neoplasms, Glandular and Epithelial 1 Meningitis 1 HIV Infections 1 Diphtheria 1 Anus Neoplasms 1

Interventions

hecolin 1 Papillomavirus Vaccines 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT01735006 2020-02-24

Efficacy and Immunogenicity Study of Recombinant Human Papillomavirus Bivalent（Type 16/18 ）Vaccine

Xiamen University

Phase 3 Completed

Persistent Infection, Uterine Cervical Dysplasia, Uterine Cervical Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡